Filing Details
- Accession Number:
- 0001209191-20-044729
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-04 17:02:15
- Reporting Period:
- 2020-07-31
- Accepted Time:
- 2020-08-04 17:02:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Commercial Physical & Biological Research (8731) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689757 | Thomas Jeffrey Elliott | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-31 | 6,638 | $21.68 | 75,861 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-31 | 1,400 | $91.18 | 74,461 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-31 | 5,633 | $92.39 | 68,828 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-31 | 9,151 | $93.30 | 59,677 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-31 | 15,604 | $94.38 | 44,073 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-31 | 5,312 | $95.11 | 38,761 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-31 | 400 | $97.42 | 38,361 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-07-31 | 6,638 | $0.00 | 6,638 | $21.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,362 | 2018-02-23 | 2027-02-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,147 | Indirect | Held in 401(k) Plan |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.77 to $91.65, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.78 to $92.77, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.82 to $93.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.84 to $94.83, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.89 to $95.65, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.40 to $97.49, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
- In addition to the shares of Common Stock reported on this Form 4, which total 39,508 shares, Mr. Elliott also holds, in the aggregate, an additional 144,847 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Billionaire Hedge Funds
